In Vitro Monoclonal Antibody Production Article Reveals Bioscience Surprises

Share this news:

BitesizeBio.com has published its latest article covering how to overcome challenges when making in vitro antibodies. Aimed primarily at bioscientists, the article shows that by optimizing three components of the system you can overcome most monoclonal antibody production issues.


BitesizeBio.com has published a new article entitled, “Taking up the Challenges of In Vitro Monoclonal Antibody Production,” which sheds light on the most important aspects of how to overcome challenges when making in vitro antibodies. Bioscientists, and other interested individuals, can view the full article on BitesizeBio.com.


The article includes several interesting pieces of information, one in particular is that by optimizing three components of the system scientists can overcome most monoclonal antibody production issues. This should be of particular interest to bioscientists because the process, while complicated, can be broken down into three discrete systems.


One of the most important piece of information the article conveys is that in vitro antibody production is viable for many labs—either in house or via a company. The best example of this is perhaps found in the following extract:


‘Whether monoclonal antibodies are produced in vitro in-house or by a company, advances in bioprocess development, media formulations, and cell line engineering make it faster and easier to optimize in vitro antibody production processes.’


In discussing the article’s creation, Dr. Amanda Welch, Edito-in-Chief at BitesizeBio.com said, “We hope that this article helps researchers troubleshoot their antibody process as well as makes them aware of possible pitfalls that they can avoid by properly designing their manufacturing process.”


This article is part of BitesizeBio’s “Sponsored Education” series, and is supported by QED Bioscience. QED Bioscience has been designing and manufacturing antibodies for over 20 years. Their goal is to provide the best antibody products and services on the market and support their customers with the top-quality antibodies and technical expertise they would expect from a full-spectrum antibody company like QED.


The editorial staff at BitesizeBio anticipate much interest and discussion generated by this article. Comments can be left on the article page, as well as on BitesizeBio’s social media channels. Subscribing to the BitesizeBio RSS feed is recommended for those looking to keep up to date with the latest content published by the website.


Release ID: 215764